Results: The PRISE internal reliability (Cronbach’s alpha) was 0.87.

Split-half reliability indexes were lambda(4) = 0.89 and lambda(6) = 0.89. Corrected Elafibranor molecular weight item-total correlation coefficients were significant for all items. The correlation of PRISE with a modified Infant Toddler Meaningful Auditory Integration Scale (IT-MAIS), collected for convergent validity measurement purposes, was good (r = 0.743). A positive correlation of PRISE scores with age was found, reflecting on the age-dependence of pre-verbal skills.

Conclusion: These findings demonstrate high reliability and convergent validity of the Italian PRISE version. This questionnaire constitutes a robust tool for assessing early language development in infants and toddlers with normal hearing. It seems particularly sensitive

to the normal language development in the first years of life, which can be very useful for early rehabilitation of hearing loss. (C) 2013 Elsevier Ireland Ltd. All rights reserved.”
“From the chloroform extract of the aerial parts of Salvia xanthocheila, one new triterpene, together with two known diterpenes, two known flavonoids and a phytosterol was isolated. On the basis of comprehensive spectroscopic analyses, including electron ionisation mass spectra, H-1-NMR, C-13-NMR, 1-D nuclear Overhauser effect, distortionless enchancement learn more by polarisation transfer, H, H correlation spectroscopy, heteronuclear multiple quantum coherence, rotating frame Overhauser enhancement spectroscopy spectra and comparison with

spectral JQ1 in vitro data of known compounds, the structure of new compounds was established as 1 beta,3 beta-dihydroxyolean-9(11),12-dienyl (1). The five known compounds (2-6) were 7 alpha-acetoxyroyleanone, taxodione, salvigenin, apigenin-7,4′-dimethyl ether and beta-sitosterol, respectively. These known structures are isolated from the aerial parts of S. xanthocheila for the first time.”
“One goal of the Patient-Reported Outcomes Measurement Information System (TM) (PROMIS (TM)) is to develop a measure of sexual functioning that broadens the definition of sexual activity and incorporates items that reflect constructs identified as important by patients with cancer. We describe how cognitive interviews improved the quality of the items and discuss remaining challenges to assessing sexual functioning in research with cancer populations.

We conducted 39 cognitive interviews of patients with cancer and survivors on the topic of sexual experience. Each of the 83 candidate items was seen by 5-24 participants. Participants included both men and women and varied by cancer type, treatment trajectory, race, and literacy level. Significantly revised items were retested in subsequent interviews.

Cognitive interviews provided useful feedback about the relevance, sensitivity, appropriateness, and clarity of the items. Participants identified broad terms (e.g.